Ralf Weiskirchen

28.5k total citations · 11 hit papers
489 papers, 19.0k citations indexed

About

Ralf Weiskirchen is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Ralf Weiskirchen has authored 489 papers receiving a total of 19.0k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Epidemiology, 170 papers in Molecular Biology and 155 papers in Hepatology. Recurrent topics in Ralf Weiskirchen's work include Liver Disease Diagnosis and Treatment (149 papers), Liver physiology and pathology (128 papers) and TGF-β signaling in diseases (32 papers). Ralf Weiskirchen is often cited by papers focused on Liver Disease Diagnosis and Treatment (149 papers), Liver physiology and pathology (128 papers) and TGF-β signaling in diseases (32 papers). Ralf Weiskirchen collaborates with scholars based in Germany, United States and Netherlands. Ralf Weiskirchen's co-authors include Frank Tacke, Axel M. Gressner, Sabine Weiskirchen, Erawan Borkham‐Kamphorst, Christian Trautwein, Christian Liedtke, O Gressner, Preethi Chandrasekaran, Nikolaus Gaßler and Steffen K. Meurer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Ralf Weiskirchen

464 papers receiving 18.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis #

2009 627 citations Ralf Weiskirchen, Tom Luedde et al. Hepatology profile →
Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF‐β as major players and therapeutic targets

2006 624 citations Axel M. Gressner, Ralf Weiskirchen profile →
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications

2018 424 citations Ralf Weiskirchen, Sabine Weiskirchen et al. profile →
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis

2017 421 citations Oliver Krenkel, Tobias Puengel et al. Hepatology profile →
The carbon tetrachloride model in mice

2015 281 citations Ralf Weiskirchen et al. profile →
Gene therapy: Comprehensive overview and therapeutic applications

2022 186 citations Ralf Weiskirchen et al. profile →
Iron metabolism: pathophysiology and pharmacology

2021 179 citations Ralf Weiskirchen et al. profile →
The Role of Obesity in Type 2 Diabetes Mellitus—An Overview

2024 156 citations Preethi Chandrasekaran, Ralf Weiskirchen International Journal of Molecular Sciences profile →
Cellular Mechanisms of Liver Fibrosis

2021 148 citations Sabine Weiskirchen, Ralf Weiskirchen et al. profile →
Effects of Probiotics on Gut Microbiota: An Overview

2024 148 citations Preethi Chandrasekaran, Sabine Weiskirchen et al. International Journal of Molecular Sciences profile →
The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis

2024 41 citations Preethi Chandrasekaran, Ralf Weiskirchen International Journal of Molecular Sciences profile →

Peers

Countries citing papers authored by Ralf Weiskirchen

Since Specialization

Citations

This map shows the geographic impact of Ralf Weiskirchen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Weiskirchen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Weiskirchen more than expected).

Fields of papers citing papers by Ralf Weiskirchen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Weiskirchen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Weiskirchen. The network helps show where Ralf Weiskirchen may publish in the future.

Co-authorship network of co-authors of Ralf Weiskirchen

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Weiskirchen. A scholar is included among the top collaborators of Ralf Weiskirchen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Weiskirchen. Ralf Weiskirchen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A data-driven machine learning algorithm to predict the effectiveness of inulin intervention against type II diabetes 2025 ·Frontiers in Nutrition ·(unknown), Ralf Weiskirchen, Wenjing Zheng, (unknown), (unknown), Zhiguo Liu, Hualin Wang	1
2	Diabetes-preventive molecular mechanisms of breast versus formula feeding: new insights into the impact of milk on stem cell Wnt signaling 2025 ·Frontiers in Nutrition ·Bodo C. Melnik, Ralf Weiskirchen, Sabine Weiskirchen, Wolfgang Stremmel, Swen Malte John, Claus Leitzmann, Gerd Schmitz	0
3	Advanced In Vitro Models for Preclinical Drug Safety: Recent Progress and Prospects 2024 ·Current Issues in Molecular Biology ·Dileep G. Nair, Ralf Weiskirchen	14
4	Sex and Gender Differences in Liver Fibrosis: Pathomechanisms and Clinical Outcomes 2024 ·(unknown), Amedeo Lonardo, Ralf Weiskirchen	15
5	Onion-skin type of periductular sclerosis in mice with genetic deletion of biliary kindlin-2 as tight junction stabilizer: a pilot experiment indicating a primary sclerosing cholangitis (PSC) phenotype 2024 ·Martina Lukasova, (unknown), Ralf Weiskirchen, Wolfgang Stremmel	2
6	Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease 2024 ·Amedeo Lonardo, Stefano Ballestri, György Baffy, Ralf Weiskirchen	5
7	Reply to “comment on ‘onion-skin type of periductular sclerosis in mice with genetic deletion of biliary kindlin-2 as tight junction stabilizer: a pilot experiment indicating a primary sclerosing cholangitis (PSC) phenotype’” 2024 ·Martina Lukasova, (unknown), Ralf Weiskirchen, Wolfgang Stremmel	1
8	Unlocking Potential: A Comprehensive Overview of Cell Culture Banks and Their Impact on Biomedical Research 2024 ·Cells ·Sabine Weiskirchen, Antônio Miguel Vieira Monteiro, Radovan Borojević, Ralf Weiskirchen	0
9	Nasopharyngeal Carcinoma Cell Lines: Reliable Alternatives to Primary Nasopharyngeal Cells? 2024 ·Cells ·Anna Makowska, Ralf Weiskirchen	3
10	Scope highlights of Annals of Translational Medicine based on a review of the history, definition, and scope of translational medicine 2023 ·Annals of Translational Medicine ·Kaiping Zhang, (unknown), Yan Peng, (unknown), Chun‐Dong Zhang, Calvin S.H. Ng, Rafael Rosell, Jimmy T. Efird, (unknown), Francesco Nappi, Ralf Weiskirchen, Shizuka Uchida, Mui Teng Chua, Riccardo D’Ambrosi	1
11	Isolation of Bovine and Human Milk Extracellular Vesicles 2023 ·Biomedicines ·Ralf Weiskirchen, Sarah K. Schröder, Sabine Weiskirchen, Eva Miriam Buhl, Bodo C. Melnik	9
12	Potential Pathogenic Impact of Cow’s Milk Consumption and Bovine Milk-Derived Exosomal MicroRNAs in Diffuse Large B-Cell Lymphoma 2023 ·International Journal of Molecular Sciences ·Bodo C. Melnik, Rudolf Stadler, Ralf Weiskirchen, Claus Leitzmann, Gerd Schmitz	12
13	The Interplay of TGF-β1 and Cholesterol Orchestrating Hepatocyte Cell Fate, EMT, and Signals for HSC Activation 2023 ·Cellular and Molecular Gastroenterology and Hepatology ·(unknown), (unknown), Mei Han, (unknown), (unknown), Roman Liebe, Ye Yao, Seddik Hammad, (unknown), (unknown), Claudia Rubie, (unknown), Matthias Glanemann, Matthias P. Ebert, Ralf Weiskirchen, Yoav I. Henis, Marcelo Ehrlich, Steven Dooley	10
14	The Pivotal Role of the Membrane-Bound O-Acyltransferase Domain Containing 7 in Non-Alcoholic Fatty Liver Disease 2023 ·SHILAP Revista de lepidopterología ·Preethi Chandrasekaran, Ralf Weiskirchen	4
15	The miR-371∼373 Cluster Represses Colon Cancer Initiation and Metastatic Colonization by Inhibiting the TGFBR2/ID1 Signaling Axis 2018 ·Cancer Research ·Pit Ullmann, Fabien Rodriguez, Martine Schmitz, Steffen K. Meurer, Komal Qureshi-Baig, Paul Felten, Aurélien Ginolhac, Laurent Antunes, Sónia Frasquilho, (unknown), Ralf Weiskirchen, Serge Haan, Elisabeth Letellier	37
16	Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis breakdown → 2017 ·Hepatology ·Oliver Krenkel, Tobias Puengel, Olivier Govaere, Ali T. Abdallah, Jana C. Mossanen, Marlene Kohlhepp, Anke Liepelt, Éric Lefebvre, Tom Luedde, Claus Hellerbrand, Ralf Weiskirchen, Thomas Longerich, Ivan G. Costa, Quentin M. Anstee, Christian Trautwein, Frank Tacke	421
17	Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis 2015 ·Journal of Visualized Experiments ·Carmen G. Tag, Sibille Sauer-Lehnen, Sabine Weiskirchen, Erawan Borkham‐Kamphorst, René H. Tolba, Frank Tacke, Ralf Weiskirchen	90
18	Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis 2015 ·Journal of Visualized Experiments ·Carmen G. Tag, Sibille Sauer-Lehnen, Sabine Weiskirchen, Erawan Borkham‐Kamphorst, René H. Tolba, Frank Tacke, Ralf Weiskirchen	248
19	Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda 2006 ·Physiological Research ·Jorge Frank, Pamela Poblete‐Gutiérrez, Ralf Weiskirchen, O Gressner, (unknown), Frank Lammert	13
20	Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis 2004 ·Laboratory Investigation ·Erawan Borkham‐Kamphorst, Jens Herrmann, Doris Stoll, (unknown), Axel M. Gressner, Ralf Weiskirchen	126

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact